Erik Stoops

Chagas disease

Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network

The glymphatic pathway in neurological disorders

Inflammation and cerebral small vessel disease: A systematic review

Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

Gut microbiome alterations in Alzheimer’s disease

Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer’s disease in late-middle-aged adults

Defining trained immunity and its role in health and disease

Single-cell transcriptomic analysis of Alzheimer’s disease

Inflammation in obesity, diabetes, and related disorders

Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ε4 genotype

A Critical Review on Chagas Disease Chemotherapy

The effects of noncoding aquaporin‐4 single‐nucleotide polymorphisms on cognition and functional progression of Alzheimer's disease

Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels

Epidemiology of Chagas disease in non endemic countries: the role of international migration

Religious Orders Study and Rush Memory and Aging Project

C-Reactive Protein, Plasma Amyloid-β Levels, and Their Interaction With Magnetic Resonance Imaging Markers

A recombinant peptide antigen line immunoassay optimized for the confirmation of Chagas' disease

Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age

Serological Confirmation of Chagas' Disease by a Recombinant and Peptide Antigen Line Immunoassay: INNO-LIA Chagas